JAK inhibitors in dermatology: The promise of a new drug class.
about
New and Emerging Targeted Systemic Therapies: A New Era for Atopic Dermatitis.Atopic dermatitis phenotypes and the need for personalized medicine.Ruxolitinib found to cause eyelash growth: a case report.Lack of an association between alopecia areata and visceral or hematopoietic cancers.Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.Efficacy and safety of tofacitinib for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.Janus kinase inhibitors for the use of alopecia areata: A promising therapeutic of the future.Upregulation of Melanogenesis and Tyrosinase Activity: Potential Agents for Vitiligo.Jak-inhibitors and UV-B: Potential combined therapy for vitiligo.Psoriasis: A STAT3-Centric View.Advances in treating psoriasis in the elderly with small molecule inhibitors.[Systemic treatment of vitiligo : Balance and current developments].Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study.What progress have we made in the treatment of atopic eczema? Putting the new biological therapies into a wider context.Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma
P2860
Q38602326-E4A54A19-893A-4759-ABD4-6F05758D37CEQ39352185-DE20100F-14CA-4985-99D5-CC53CBAB893FQ41003544-CD5ACCEC-EB7A-43F1-8F9E-C295EAB8DC0BQ46468413-75C31F20-08D8-44CE-AFC9-53BB5F514094Q47331730-0A1F3FB2-45EC-41AF-9D9B-A26B1060E43EQ47349992-2654ACD5-E7DD-45E4-AFB3-2152614723FBQ47847063-B199B620-542C-4225-B0DD-27C6D47667C3Q47991119-2C224FB7-40FC-4BD0-B045-26908284001FQ48189491-46CDD520-CD9B-46AB-A2A5-0B76C50D2684Q48278607-0B181C10-7DC4-42E0-A526-ACCD479AB63AQ49679446-9F5F40D4-28C0-4BD1-B950-929381767D90Q50067269-E8764B2C-F718-4F47-B134-0D365642734AQ50272808-3A54DDED-4700-4DEB-9A2E-7FD5A9409369Q53150404-648A2B75-D1A6-4830-89EB-FAE16A33FC38Q58760715-68DC4C02-FB42-4D91-B102-51621AF610E5
P2860
JAK inhibitors in dermatology: The promise of a new drug class.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
JAK inhibitors in dermatology: The promise of a new drug class.
@en
JAK inhibitors in dermatology: The promise of a new drug class.
@nl
type
label
JAK inhibitors in dermatology: The promise of a new drug class.
@en
JAK inhibitors in dermatology: The promise of a new drug class.
@nl
prefLabel
JAK inhibitors in dermatology: The promise of a new drug class.
@en
JAK inhibitors in dermatology: The promise of a new drug class.
@nl
P2860
P1476
JAK inhibitors in dermatology: The promise of a new drug class.
@en
P2093
Brett A King
William Damsky
P2860
P304
P356
10.1016/J.JAAD.2016.12.005
P407
P577
2017-01-28T00:00:00Z